Poolbeg Pharma Merger Plan Gets Backing From Hookipa Shareholder

📆 07/01/2025 13:28:00
📰 IrishTimes

⏱ Reading Time:
35 sec. here
7 min. at publisher
📊 Quality Score:
News: 34%
Publisher: 98%

Business Notizia

MERGER,PHARMACEUTICALS,BIOPHARMACEUTICAL

Poolbeg Pharma, a clinical-stage biopharmaceutical company, announced that its merger plan with Nasdaq-listed Hookipa Pharma has received support from a major shareholder, US biopharma giant Gilead. Gilead, which owns 19.4% of Hookipa, plans to back the merger if an agreement is reached between the two companies.

A plan by Poolbeg Pharma, the clinical-stage biopharmaceutical company led by serial entrepreneur Cathal Friel , to merge with Nasdaq-listed peer Hookipa Pharma has secured backing from a major shareholder in the target company.

Irish-based, but London-listed, Poolbeg said on Tuesday that US biopharma giant Gilead, which owns 19.4 per cent of Hookipa, plans to support a merger if an agreement between both companies is reached. A planned $30 million equity raise immediately after the tie-up would dilute the stakes of legacy investors in both. Poolbeg’s shareholders holding in the combined entity may fall to about 40 per cent as a result, both companies said last week.Shares in Hookipa, where Irish life sciences industry veteran Julie O’Neill is chairperson, slumped by almost 76 per cent in 2023 as the company went through senior management changes and announced three rounds of large job cuts.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

Scrivi un Commento

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

Advertising revenues set to hit $1tn in market dominated by technology companiesOmnicom and Interpublic in talks to merge in $30bn-plus deal to create the world’s largest advertising agency
Fonte: IrishTimes - 🏆 3. / 98 Leggi di più »